(Q33636111)

28 July 2017

1 reference

title

The role of Fas and related death receptors in autoimmune and other disease states (English)

1 reference

28 July 2017

Siegel RM

1 reference

28 July 2017

Fleisher TA

series ordinal

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

The Journal of Allergy and Clinical Immunology

28 July 2017

1 reference

inferred from page(s)

published in

1 reference

28 July 2017

volume

103

1 reference

28 July 2017

issue

5 Pt 1

1 reference

28 July 2017

page(s)

729-738

1 reference

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Caspases: killer proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A novel domain within the 55 kd TNF receptor signals cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A death-domain-containing receptor that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Characterization of two receptors for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

NMR structure and mutagenesis of the FADD (Mort1) death-effector domain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

An induced proximity model for caspase-8 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Origin and selection of peripheral CD4-CD8- T cells bearing alpha/beta T cell antigen receptors in autoimmune gld mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Self-tolerance checkpoints in B lymphocyte development

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Self-reactive B cells in nonautoimmune and autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Dendritic cells in the T-cell areas of lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Essential roles of the Fas ligand in the development of hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Contribution of Fas ligand to T cell-mediated hepatic injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Immune response and myoblasts that express Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Pathological findings in human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Clinical, immunological, and pathological consequences of Fas-deficient conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas system and apoptosis in viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Fas antigen/APO-1 (CD95) expression on myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970412-4

7 January 2021

10.1016/S0091-6749(99)70412-4

Identifiers

DOI

1 reference

28 July 2017

1 reference